New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Nutrition 21, Glanbia sign promotion, distribution deal

Nutrition 21, Glanbia sign promotion, distribution deal
Agreement brings together leaders in innovative nutritional ingredients whose health benefits are substantiated by clinical research.

Nutrition 21 LLC, a leading developer and marketer of nutritional ingredients whose health benefits are substantiated by extensive clinical research, announced today a distribution and co-promotion agreement with Glanbia Nutritionals (NA) Inc., a global ingredient and nutritional premix company. As exclusive distributor, Glanbia’s capable sales organization will comarket, with Nutrition 21, Chromax® chromium picolinate, Selenomax® high selenium yeast, SelenoPure® L-selenomethionine and Zinmax® zinc picolinate, in North America to the food, beverage and dietary supplement industries.

“As an innovative ingredient with impressive scientific support, Chromax chromium picolinate is an excellent addition to our current product line,” said Richard Hazel, CEO of Glanbia Nutritionals. “We are excited to work with Nutrition 21 to increase their current market presence and to add Chromax chromium picolinate and other Nutrition 21 ingredients to our ingredient portfolio.”

Commenting on the announcement, Michael Satow, CEO of Nutrition 21, stated, "We are enthusiastic about the future commercial impact of this relationship. Glanbia’s superb sales, marketing and R&D teams make them the ideal partner for Nutrition 21. Our combined sales force will number over 20 industry-astute professionals. Among other things, we look forward to promoting our recent Chromax GRAS affirmation at doses up to 2000 mcg of chromium per day.”

Chromax chromium picolinate is a perfect nutrient to formulate into products positioned to address many of the health and lifestyle issues that are of increasing concern to the American population, such as cognitive function, weight management, food cravings, mood and support for healthy glucose metabolism. “With more than 43 human clinical studies in more than 2,300 human subjects and more than 20 active and pending compositions of matter and use patents, Chromax, made in the U.S., is the only form of clinically efficacious dietary chromium that has been reviewed for safety and allowed for marketing by regulatory governing bodies in the US, EU and Canada,” said James Komorowski, MS, CNS, vice president of scientific and regulatory affairs at Nutrition 21.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.